You are viewing: Brunei ASEAN Point of Care Diagnostics Market analysis

The Brunei ASEAN Point of Care Diagnostics Market was valued at $11.63 Million in 2025 and projected to reach to $13.45 Million by 2030, representing a compound annual growth rate of 3.0%. Brunei's point of care diagnostics market is positioned for steady growth through 2030, driven by the nation's commitment to healthcare modernization and improved diagnostic accessibility.

Brunei ASEAN Point of Care Diagnostics Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Brunei ASEAN Point of Care Diagnostics Market Trends and Insights

  • This steady growth reflects Brunei's commitment to advancing healthcare infrastructure and improving diagnostic accessibility across its healthcare system.
  • Brunei's market is driven by increasing demand for rapid, accurate diagnostic solutions in both clinical and community settings, supported by the nation's focus on preventive healthcare and early disease detection. The point of care diagnostics sector in Brunei benefits from rising healthcare expenditure and a growing emphasis on point-of-care testing in primary care facilities.
  • Brunei's relatively small but affluent population and well-developed healthcare system create favorable conditions for adoption of advanced diagnostic technologies.
  • Between 2025 and 2030, Brunei is expected to see enhanced integration of POC testing in routine clinical practice, driven by technological innovation and improved reimbursement frameworks that support diagnostic accessibility..

Key Market Statistics

  • CAGR (2025-2030) 3.0% CAGR
  • Market Size, 2025 ~USD 11.63 Million
  • Forecast, 2030 ~USD 13.45 Million
  • Country Brunei

Brunei ASEAN Point of Care Diagnostics Market Overview

Market Size & Growth :

Brunei's point of care diagnostics market is valued at USD 11.63 million in 2025, with projected growth to USD 13.45 million by 2030, representing a steady 3.0% CAGR aligned with regional healthcare expansion.

Healthcare Infrastructure Development :

Brunei is actively advancing its healthcare infrastructure with increased investment in diagnostic accessibility, supporting the adoption of point of care testing across primary and secondary care facilities.

Rapid Diagnostic Demand :

Growing demand for rapid diagnostic solutions in Brunei is driven by the need for faster patient turnaround times, improved disease management, and enhanced preventive healthcare capabilities across the nation.

Government Healthcare Initiatives :

Brunei's government-backed healthcare modernization programs are facilitating the integration of point of care diagnostics into clinical workflows, supporting market penetration and technology adoption.

Brunei ASEAN Point of Care Diagnostics Market Dynamics

  • The 3.0% CAGR reflects consistent investment in healthcare infrastructure and the increasing adoption of rapid testing solutions across Brunei's medical facilities.
  • Government initiatives supporting healthcare advancement and rising demand for efficient diagnostic tools are key growth catalysts. The market outlook for Brunei remains positive as healthcare providers prioritize point of care testing to enhance clinical efficiency and patient outcomes.
  • Continued government support, coupled with growing awareness of rapid diagnostics' benefits, will sustain market expansion.
  • Strategic partnerships between local healthcare institutions and diagnostic manufacturers are expected to further accelerate market penetration and innovation in Brunei's healthcare sector..

Related Ecosystem

Key Takeaways

  • Brunei's point of care diagnostics market is valued at USD 11.63 million in 2025 with a projected value of USD 13.45 million by 2030.
  • Brunei's market is growing at a 3.0% CAGR, reflecting steady expansion driven by healthcare modernization and preventive care initiatives.
  • Brunei's affluent healthcare system and small population create a concentrated market with high adoption potential for advanced diagnostic technologies.
  • Between 2025 and 2030, Brunei is expected to strengthen POC testing integration in primary care and community health settings.

ASEAN Point of Care Diagnostics Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment RESPIRATORY INFECTION TESTING PRODUCTS (Disease Type)
Forecast Period 2025-2030
Growth Rate CAGR of 4.7% from 2025 to 2030
Largest Segment BIOCHEMISTRY (Technology)
Market Size Base Year (Billions) ~USD 1.08 (2025)
Revenue Forecast (Billions) ~USD 1.36 (2030)
Segments Covered Product, Type, Disease Type, Technology, End User

Brunei ASEAN Point of Care Diagnostics Market Report Segmentation

5 segment dimensions are covered across the global market.

By Product

  • Cancer Marker Testing Products
  • Cardiometabolic Testing Products
  • Cholesterol Testing Products
  • Coagulation Monitoring Products
  • Drugs-Of-Abuse Testing Products
  • Fecal Occult Testing Products
  • Glucose Monitoring Products
  • Hematology Testing Products
  • Infectious Disease Testing Products
  • Other Poc Products
  • Pregnancy & Fertility Testing Products
  • Urinalysis Testing Products

By Type

  • Blood Gas & Electrolyte Testing Products
  • Cardiac Marker Testing Products
  • Glucometers
  • Glucose Test Strips
  • Hba1C Testing Products
  • Hepatitis B Testing Products
  • Hepatitis C Testing Products
  • Influenza Testing Products
  • Lancets
  • Other Respiratory Infection Testing Products
  • Tb Testing Products

By Disease Type

  • Hai Testing Products
  • Hepatitis Testing Products
  • Hiv Testing Products
  • Hospital-Acquired Infection Testing Products
  • Mosquito-Borne Disease Testing Products
  • Other Infectious Disease Testing Products
  • Respiratory Infection Testing Products
  • Std Testing Products

By Technology

  • Biochemistry
  • Lateral Flow Assays (Immunoassays)
  • Rapid Tests (Molecular Diagnostics)

By End User

  • Clinical Laboratories
  • Home Care Settings
  • Hospitals And Critical Care Centers
  • Other End Users
  • Outpatient Settings And Ambulatory Care Centers

BRUNEI: ASEAN POINT OF CARE DIAGNOSTICS MARKET, BY END USER, 2022–2030

Segment20222023202420252026202820292030CAGR (%)
CLINICAL LABORATORIES4.174.124.094.094.114.234.324.451.7
HOME CARE SETTINGS5.195.235.315.435.575.996.266.64
HOSPITALS AND CRITICAL CARE CENTERS1.141.141.151.161.181.251.291.353.1
OTHER END USERS0.320.320.310.310.310.320.320.331.3
OUTPATIENT SETTINGS AND AMBULATORY CARE CENTERS0.640.630.630.640.640.670.690.722.4
TOTAL11.4711.4411.511.6311.8212.4512.913.453

Target Audience

  • Diagnostic Device Manufacturers : Manufacturers need Brunei-specific market data to assess market size, growth potential, and localized demand for point of care testing solutions to guide product development and market entry strategies.
  • Healthcare Providers & Hospitals : Brunei's healthcare institutions require market insights to understand diagnostic technology trends, procurement opportunities, and competitive offerings to optimize their diagnostic capabilities and patient care.
  • Investment & Private Equity Firms : Investors targeting Brunei's healthcare sector need detailed market analysis, growth forecasts, and opportunity assessment to identify viable investment opportunities in the point of care diagnostics space.
  • Government & Healthcare Policymakers : Brunei's healthcare authorities and policymakers require market data to inform healthcare infrastructure planning, diagnostic accessibility initiatives, and evidence-based healthcare modernization strategies.
  • Distributors & Healthcare Suppliers : Distributors operating in Brunei need market-specific intelligence on demand patterns, growth trajectories, and competitive landscape to optimize inventory, partnerships, and sales strategies.

Reasons to Buy this Report

  • Brunei-Specific Market Sizing : Access precise market valuation data for Brunei's point of care diagnostics sector with accurate 2025 baseline (USD 11.63M) and 2030 forecasts, enabling confident investment and expansion planning.
  • Growth Trajectory Analysis : Understand Brunei's 3.0% CAGR within the broader 4.7% global context, identifying localized growth drivers and market dynamics specific to Brunei's healthcare ecosystem.
  • Healthcare Infrastructure Insights : Gain detailed intelligence on Brunei's healthcare modernization initiatives, government support mechanisms, and diagnostic accessibility improvements driving market expansion.
  • Competitive Positioning Strategy : Develop targeted market entry and expansion strategies for Brunei by understanding local demand patterns, healthcare provider preferences, and regulatory environment specific to the nation.
  • Investment Decision Support : Make informed investment decisions in Brunei's healthcare diagnostics sector with comprehensive market analysis, growth forecasts, and opportunity identification tailored to this emerging market.

Frequently asked questions

What is the current market size of point of care diagnostics in Brunei?

Brunei's point of care diagnostics market is estimated at USD 11.63 million in 2025.

What is the projected market size for Brunei's POC diagnostics by 2030?

Brunei's point of care diagnostics market is forecast to reach USD 13.45 million by 2030.

What is the growth rate of Brunei's point of care diagnostics market?

Brunei's point of care diagnostics market is expanding at a compound annual growth rate of 3.0% from 2025 to 2030.

What factors are driving growth in Brunei's POC diagnostics market?

Growth in Brunei is driven by rising healthcare expenditure, emphasis on preventive care, technological innovation, and improved reimbursement frameworks supporting diagnostic accessibility.

How does Brunei's market compare to other ASEAN nations?

Brunei's 3.0% CAGR reflects a steady, stable market growth trajectory supported by its well-developed healthcare infrastructure and affluent population base.

RESEARCH METHODOLOGY

The study involved major activities in estimating the current market size for the ASEAN point of care diagnostics market. Exhaustive secondary research was done to collect information on the ASEAN point of care diagnostics industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ASEAN point of care diagnostics market.

The four steps involved in estimating the market size are:

Secondary Research

In the secondary research process, various secondary sources, such as company annual reports, press releases, and investor presentations, white papers, certified publications, articles by recognized authors, gold-standard and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were referred to identify and collect information for this study.

Primary Research

In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.

The following is a breakdown of the primary respondents:

Asean Point of Care Diagnostics Market

Note 1: Others include sales, marketing, and product managers.

Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME DESIGNATION
PTS Diagnostics Regional Sales Manager
EKF Diagnostics Holdings plc Product Manager

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the ASEAN point of care diagnostics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • Primary and secondary research has determined the revenues of leading players operating in the ASEAN point of care diagnostics market.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

The research methodology used to estimate the market size includes the following:

Asean Point of Care Diagnostics Market

Data Triangulation

After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Point of care testing (POCT) includes tests designed to be used at or near the patient's site (such as at home, in an ambulance, at a physician’s office, and other locations). POCT allows rapid & reliable diagnostic testing to obtain outcomes instantly, helping physicians/patients make care decisions remotely and rapidly.

Stakeholders

  • Senior Management
  • End User
  • Finance/Procurement Department  
  • R&D Department

Report Objectives

  • To define, describe, segment, and forecast the ASEAN point of care diagnostics market based on product, technology, end user, and country
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall ASEAN point of care diagnostics market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to ten countries, namely, Vietnam, Laos, Cambodia, Malaysia, Myanmar, Philippines, Singapore, Thailand, Indonesia, and Brunei
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
  • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business & product excellence

Get the Full ASEAN Point of Care Diagnostics Market Report

Full forecast, segment splits, and company analysis for all ASEAN Point of Care Diagnostics Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status